Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SMAD5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MET - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DR1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZMYM4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CDC23 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC8A1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TWF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
SUGP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MCM4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HERPUD1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ANXA1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IGF1R - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZFY - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
MAF - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TRIM10 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MIR3652 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MIR21 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HSPE1-MOB4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC401317 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on